Poor glycemic control associates with high intravitreal angiopoietin-2 levels in patients with diabetic retinopathy.
Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.
Raimo
R
Tuuminen
Hjelt Institute, University of Helsinki, Helsinki, Finland.
Jari
J
Haukka
Unit of Vitreoretinal Surgery, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.
Sirpa
S
Loukovaara
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D042702:Angiopoietin-2 / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000378:metabolism* / Q000601:surgery; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D014821:Vitrectomy; D014822:Vitreous Body / Q000378:metabolism*; D055815:Young Adult
D042702:Angiopoietin-2; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D042461:Vascular Endothelial Growth Factor A; C467484:VEGFA protein, human; C517652:hemoglobin A1c protein, human